HUMAN PAPILLOMAVIRUS INFECTION

This study is testing a vaginal insert called ABI-2280 to see if it can safely clear persistent, high-risk HPV infections in women. About 141 women aged 25-55 with a long-term HPV infection will receive either the active insert or a placebo. The main goal is to see if the treatme…

This study aims to find better ways to screen men for early signs of cancers caused by HPV, particularly in the throat and genital areas. Researchers are testing whether specific markers in blood and oral samples can identify men at higher risk before cancer develops. About 1,500…

This study is testing whether a vaginal sample you collect yourself at home is as good at finding the HPV virus as a sample a doctor collects during a pelvic exam. It involves 520 women who are already scheduled for a follow-up cervical exam. The goal is to make cervical cancer s…

This study is testing whether people can collect their own vaginal samples for HPV testing as accurately as a doctor can collect cervical samples during a pelvic exam. The goal is to make cervical cancer screening more accessible and comfortable, especially for those who avoid cl…

This study is testing a program called PC TEACH, which helps rural primary care clinics use proven strategies to increase HPV vaccination among adolescents. The goal is to prevent future cancers caused by the human papillomavirus. The program works with clinics over 12 months to …

This study is testing different methods to encourage more young adults in Texas to get vaccinated against HPV, a virus that can cause several cancers. Researchers are comparing six different approaches that include providing standard information, personal stories in video or writ…

This study is testing if mailing a simple, at-home HPV test kit can help more Asian and Asian American women get screened for cervical cancer. It focuses on women in a safety-net healthcare system who are overdue for their regular screening. The goal is to see if this convenient,…

This study is testing whether the HPV vaccine, which helps prevent certain cancers, can still help build a strong immune response in people who are about to receive a kidney transplant. Kidney transplant patients must take powerful drugs to prevent organ rejection, but these drug…

This study is testing whether offering easy-to-use, at-home HPV swab kits at walk-in clinics with evening and weekend hours can help more women get screened for cervical cancer. It will involve 500 women aged 30-63 who are overdue for their regular screening. Researchers will com…

This study is testing whether people can collect their own vaginal samples at home for HPV testing as accurately as a doctor collects samples in a clinic. It involves 500 people who have already been referred for a follow-up cervical exam. The goal is to make cervical cancer scre…

This study is testing whether a single dose of the HPV vaccine is just as effective as the standard two doses at preventing infections that cause cervical cancer. It involves over 27,000 girls aged 12-16 in Costa Rica, comparing two different HPV vaccines. The goal is to make vac…

This study is following thousands of women in Costa Rica for 10 years to see how well the HPV vaccine protects against cervical cancer over the long term. Researchers are comparing women who received the vaccine years ago with a new group of unvaccinated women. The goal is to und…

This study follows women for up to 20 years after they received HPV vaccines to see how long protection lasts. Researchers are comparing women who got one, two, or three doses to understand if fewer doses provide enough long-term immunity. By testing blood samples over time, they…